Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Merck

Tag: Merck

Merck nemtabrutinib discontinued infographic: three Phase 3 BELLWAVE CLL trials stopped
  • Pharmaceuticals

Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review

Megan Wood56 minutes ago09 mins

Merck ended all development of its non-covalent BTK inhibitor nemtabrutinib after a monitoring committee flagged benefit-risk concerns in Phase 3 BELLWAVE-011. The trials, the reasons and what comes next.

Read More
Tulisokibart hidradenitis suppurativa: Merck Phase 2b trial meets primary endpoint
  • Pharmaceuticals

Tulisokibart Hidradenitis Suppurativa Trial Meets Endpoint

Megan Wood2 months ago1 month ago010 mins

Tulisokibart hidradenitis suppurativa results: Merck’s Phase 2b trial met its HiSCR50 primary endpoint at week 16, with 72% response on the high dose.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (359)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (107)
  • Uncategorized (1)

Recent Posts

  • Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review
  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.